Evidence map›Paper›PMID 35336074›Full record

ReviewMicroorganisms2022

SARS-CoV-2-Legionella Co-Infections: A Systematic Review and Meta-Analysis (2020-2021).

Matteo Riccò, Pietro Ferraro, Simona Peruzzi, Alessandro Zaniboni, Silvia Ranzieri

Abstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Severe Legionnaires' disease.Annals of intensive care · 2024
    Review
  3. Article
  4. Editorial: Special Issue: "Microorganisms · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matteo RiccòAUSL-IRCCS di Reggio Emilia, Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), Local Health Unit of Reggio Emilia, 42122 Reggio Emilia, Italy.ORCID 0000-0002-6525-2159
Pietro FerraroServizio di Medicina del Lavoro, ASL di Foggia, 71121 Foggia, Italy.ORCID 0000-0002-9149-1647
Simona PeruzziAUSL-IRCCS di Reggio Emilia, Laboratorio Analisi Chimico Cliniche e Microbiologiche, Ospedale Civile di Guastalla, 42016 Guastalla, Italy.ORCID 0000-0002-4247-5886
Alessandro ZaniboniDepartment of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Silvia RanzieriDepartment of Medicine and Surgery, University of Parma, 43126 Parma, Italy.ORCID 0000-0002-9607-8624

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legionnaires' Disease (LD) is a severe, sometimes fatal interstitial pneumonia due to

Indexed as

COVID-19diagnosisepidemiologyLegionella pneumophila typingLegionnaires’ diseaseSARS-CoV-2

Identifiers

PMID35336074
PMCPMC8951730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.